No Action Seen After Hearing On Policy Office

WASHINGTON-Congress has several options to strengthen the effectiveness of the White House science adviser and the Office of Science and Technology Policy (OSTP). But a hearing last month, more tame than some had expected, made clear that no changes are contemplated before the next president takes office. Part of the perception of weakness was attributed to the relatively low profile of the current adviser, William R. Graham; OSTP's modest budget of less than $2 million, and its small staff o

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Part of the perception of weakness was attributed to the relatively low profile of the current adviser, William R. Graham; OSTP's modest budget of less than $2 million, and its small staff of 15 permanent and 20 temporary full-time employees. "All of us can agree that this activity is vastly under-manned," testified Edward David Jr., science adviser to President Nixon. "In fact, I would call the level of manning and budget ludicrously small."

But Graham, as the lead witness, stated that OSTP's staffing and operations were adequate. He said he would recommend a similar arrangement for the new administration. Although subcommittee members clearly favored a larger and more active OSTP, the hearing before the House Subcommittee on Science, Research and Technology was held "to put on record possible suggestions for ways to strengthen OSTP," said subcommittee aide Jim Wilson.

"From a congressional standpoint, it's hard to affect anything other than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.

Published In

Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb